Stroke: prediction, prevention, and outcome.
Donnan
Geoffrey A
GA
National Stroke Research Institute, Austin & Repatriation Medical Centre, University of Melbourne, Heidelberg West, Victoria, Australia. gdonnan@unimelb.edu.au
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000235:genetics; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000235:genetics / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4